Skip to main content

Zydus Lifesciences launches generic drug for overactive bladder in US market

Zydus Lifesciences launches generic drug for overactive bladder in US market The company has launched Mirabegron extended-release tablets in strength of 25 mg in the US market after having received final approval from the US Food and Drug Administration (USFDA), Zydus Lifesciences said in a regulatory filing.

from Moneycontrol Business News https://ift.tt/O8Q6rud
Labels:

Comments

Post a Comment

Popular posts from this blog

German cabinet to hold secret session on Huawei#39;s role in 5G network: Report

Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology for spying, which the company denies. from Moneycontrol Business News http://bit.ly/2TyXzFb
Post a Comment
Read more

Infosys partners Avaloq to strengthen wealth management capabilities via digital platforms

Infosys will be a strategic implementation partner for Avaloq#39;s wealth management suite of solutions to help clients modernize and transform their legacy systems into cutting-edge digital advisory platforms, a statement said. from Moneycontrol Business News https://ift.tt/2THaSpn
Post a Comment
Read more